Tag Archives: cancer survivors

EACVI 2025 Study Finds Severe Valve Disease Raises Mortality Risk in Cancer Patients but Treatment Markedly Improves Outcomes

Posted on 11, December 2025 by EuropaWire PR Editors

(IN BRIEF) A major observational study presented at EACVI 2025 found that valvular heart disease is common in patients with prior cancer diagnoses, with 7.2% showing severe disease on echocardiography. Conditions such as tricuspid and mitral regurgitation and aortic stenosis … Read the full press release →

Posted in Artificial Intelligence (AI), Austria, Business, Education, France, Healthcare, Industrial, Management, Marketing, News, Non Profit, Pharma & Biotech, Science, Technology

Tagged anthracyclines, Aortic Stenosis, cancer survivors, cardio-oncology, cardiotoxicity, cardiovascular death, Cardiovascular Imaging, CESAR study, EACVI 2025, echocardiography, ESC, European Association of Cardiovascular Imaging, European Society of Cardiology, Maximilian Autherith, mitral regurgitation, mortality risk, New Research Highlights Need for Regular Cardiac Monitoring as Cancer Survivors Face High Rates of Valvular Heart Disease, survival benefit, tricuspid regurgitation, valve intervention, valvular heart disease, Vienna